| Frailty, kidney function, and polypharmacy: the atherosclerosis risk in communities (ARIC) study SH Ballew, Y Chen, NR Daya, JG Godino, BG Windham, ... American Journal of Kidney Diseases 69 (2), 228-236, 2017 | 126 | 2017 |
| Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study Y Chen, LR Zelnick, K Wang, AN Hoofnagle, JO Becker, C Hsu, ... Journal of the American Society of Nephrology, 2020 | 51 | 2020 |
| Serum potassium, mortality, and kidney outcomes in the atherosclerosis risk in communities study Y Chen, AR Chang, MAMA DeMarco, LA Inker, K Matsushita, SH Ballew, ... Mayo Clinic Proceedings 91 (10), 1403-1412, 2016 | 51 | 2016 |
| Race, serum potassium, and associations with ESRD and mortality Y Chen, Y Sang, SH Ballew, A Tin, AR Chang, K Matsushita, J Coresh, ... American journal of kidney diseases 70 (2), 244-251, 2017 | 45 | 2017 |
| Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor Y Li, T Huang, B Lou, D Ye, X Qi, X Li, S Hu, T Ding, Y Chen, Y Cao, M Mo, ... European journal of medicinal chemistry 163, 864-882, 2019 | 21 | 2019 |
| Prediction of Kidney Drug Clearance: A Comparison of Tubular Secretory Clearance and Glomerular Filtration Rate Y Chen, LR Zelnick, AN Hoofnagle, CK Yeung, LM Shireman, B Phillips, ... Journal of the American Society of Nephrology, 2020 | 19 | 2020 |
| Alterations of proximal tubular secretion in autosomal dominant polycystic kidney disease K Wang, LR Zelnick, Y Chen, AN Hoofnagle, T Watnick, S Seliger, ... Clinical Journal of the American Society of Nephrology 15 (1), 80-88, 2020 | 16 | 2020 |
| Association of tubular solute clearances with the glomerular filtration rate and complications of chronic kidney disease: the Chronic Renal Insufficiency Cohort study Y Chen, LR Zelnick, K Wang, R Katz, AN Hoofnagle, JO Becker, CY Hsu, ... Nephrology Dialysis Transplantation, 2020 | 11 | 2020 |
| Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease BK Ke Wang, Leila R Zelnick, Andrew N Hoofnagle, Yan Chen, Ian H de Boer ... Nephrology Dialysis Transplantation, 2019 | 9* | 2019 |
| Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study Y Chen, LR Zelnick, MP Huber, K Wang, N Bansal, AN Hoofnagle, ... American Journal of Kidney Disease, 2021 | 7 | 2021 |
| CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes D Mullins, K Pantalone, K Betts, J Song, A Wu, Y Chen, S Kong, R Singh Kidney Medicine 4 (11), 2022 | 6 | 2022 |
| Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia LE Roeker, M DerSarkissian, K Ryan, Y Chen, MS Duh, SK Wahlstrom, ... Blood Advances 7 (16), 4291-4301, 2023 | 5 | 2023 |
| Association of Tubular Solute Clearance with Symptom Burden in Incident Peritoneal Dialysis K Wang, M Nguyen, Y Chen, Andrew N. Hoofnagle, JO Becker, ... Clinical Journal of the American Society of Nephrology, 2020 | 5 | 2020 |
| Metabolomic Profiling Identifies New Endogenous Markers of Tubular Secretory Clearance M Granda, D Prince, O Fiehn, Y Chen, C Yeung, A Hoofnagle, ... Kidney 360, 2022 | 3 | 2022 |
| Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for … J Weber, T Poretta, B Stwalley, L Sakkal, E Du, T Wang, Y Chen, Y Wang, ... Cancer Immunology, Immunotherapy, 2022 | 2 | 2022 |
| Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs J Apple, M DerSarkissian, A Shah, R Chang, Y Chen, X He, J Chun Journal of Comparative Effectiveness Research, 2023 | 1 | 2023 |
| Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real‑world data J Moser, S Bhatia, A Amin, A Pavlick, K Betts, E Du, T Poretta, K Shelley, ... Cancer Immunology, Immunotherapy, 2024 | | 2024 |
| Propensity weighted indirect treatment comparison of nivolumab (NIVO) versus placebo (PBO) as adjuvant therapy for resected melanoma: A number needed to treat and overall … JS Weber, T Poretta, B Stwalley, L Sakkal, EX Du, T Wang, Y Chen, ... Journal of Clinical Oncology 39 (15_suppl), 9572-9572, 2021 | | 2021 |
| 2-alkyloxy benzene formyl arylamine compound and pharmaceutical use thereof D Ye, Y Li, L Zhou, P Wang, Y Chu, H Gong, Q Huang, Y Chen, Z Zhang US Patent 10,196,359, 2019 | | 2019 |
| 2-Alkyloxy benzene formyl arylamine compound and pharmaceutical use thereof D Ye, Y Li, L Zhou, P Wang, Y Chu, H Gong, Q Huang, Y Chen, Z Zhang CN Patent cn ZL 201410419334.2, 2018 | | 2018 |
